Recent News

ABC’s FCC filing over “The View” is a warning about how regulatory power can chill political speech without ever needing an outright ban.

Reported HHS discussions about banning some SSRI antidepressants show how public-health trust breaks when agencies confuse reform with shock politics.

Anthropic’s reported $1.8 billion Akamai compute deal shows AI’s real bottleneck is becoming infrastructure control, not chatbot demos.

Virginia’s supreme court struck down Democratic-drawn congressional maps in a 4-3 ruling — not because gerrymandering is wrong, but because Democrats didn’t follow the procedural rules for overriding their own reform.

The Trump administration’s border spending has triggered an AI surveillance gold rush — and the companies racing to sell drone-and-camera systems to ICE aren’t going to stop at the border.

Trump plans to fire FDA chief Makary after criticism from pharma, conservative media, and anti-abortion groups — revealing how political pressure hollows out the one agency Americans trust to keep drugs safe.

A federal judge’s rebuke of DOGE’s AI-assisted grant cancellations is a reminder that even popular cuts need lawful process.

EPA’s planned PFAS rollback is not just a technical fight over chemicals. It is a test of whether public-health rules can survive political regime change.

A New York pilot shows why the next energy fight is not just power plants. It is who controls the flexible demand inside ordinary homes.

Tennessee enacted a new map erasing the state’s only majority-Black House district within a week of the Supreme Court’s Voting Rights Act ruling—the first of several Southern states expected to follow.